论文部分内容阅读
一、现状人类肿瘤免疫的研究已将近一个世纪了。早在上世纪末,就有人用免疫血清(被动免疫)治疗人类肿瘤,但结果大都失败。自本世纪初以来,临床工作者不断报道用主动免疫治疗肿瘤,取得了一定效果。1904年,美国人 H.R Gaylord 搏士首先观察到了恶性肿瘤免疫学反应,1918年 Rondenberg 报告了302例肿瘤自发消退现象,本世纪六十年代,肿瘤免疫已成为现代肿瘤研究中进展很快的一个新领域。1962年,从胎盘中提取促贫血因子(P—62)
I. The current state of human tumor immunology has been studied for nearly a century. As early as the end of the last century, people used immune serum (passive immunity) to treat human tumors, but the results mostly failed. Since the beginning of this century, clinicians have continuously reported that active immunotherapy for tumors has achieved certain results. In 1904, American HR Gaylord P. first observed the immunological reaction of malignant tumors. In 1918, Rondenberg reported the spontaneous regression of 302 tumors. In the 1960s, tumor immunity has become a new one in modern tumor research. field. In 1962, anemia-producing factor was extracted from the placenta (P-62)